The contractor shall assist niaid in the planning and implementation of two separate meetings to be held at a federal conference center. An initial daids-industry pediatric formulation partnership…
Ended Awarded Last action
- Contract number
- 75N93020F00004
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $229,136
Award facts
- Opportunity
-
- 75N93020F00139 Solicitation number
- Contract value 100% obligated
- $229,136.49 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$10,714 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $137,941 | |
| Other Administrative Action | $0 | |
| Original award | $101,909 |
About this award
This federal contract award, valued at $229,136.49, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Advanced Bioscience Laboratories, Inc. (ABL). The contract is for ABL to assist NIAID in planning and implementing two separate meetings focused on potential ways to leverage private sector partnerships for pediatric formulation development. This contract is a delivery order under the larger "HIV Microbicides and Biomedical Prevention 2016-2021" program. The contract does not have a set-aside designation, indicating ABL is a large business contractor. ABL is a leading contract research and manufacturing organization specializing in the development of gene therapies, vaccines, oncolytics, and immunotherapies. The company has significant experience supporting federal agencies, including NIAID, National Cancer Institute (NCI), and National Institute of Neurological Disorders and Stroke (NINDS), on various infectious disease and medical countermeasure development programs.
Description
The contractor shall assist niaid in the planning and implementation of two separate meetings to be held at a federal conference center. An initial daids-industry pediatric formulation partnership meeting will focus on potential ways to leverage priv
Quick answers
Who was awarded contract 75N93020F00004?
75N93020F00004 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 1, 2020.
How much is contract 75N93020F00004 worth?
The government has obligated $229,136 on 75N93020F00004.
Is contract 75N93020F00004 an order under another contract?
Yes. 75N93020F00004 is a delivery order under HHSN272201600008I, an indefinite delivery contract, on HIV Microbicides and Biomedical Prevention 2016-2021.
Was contract 75N93020F00004 competed?
The extent of competition for 75N93020F00004 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award